上海建发致新医疗科技集团股份有限公司 关于变更保荐代表人的公告

Core Viewpoint - The company has undergone a change in its sponsor representatives for its initial public offering (IPO) project on the Shenzhen Stock Exchange's ChiNext board, with the appointment of a new representative to ensure continued compliance with regulatory requirements [1][2]. Group 1: Change in Sponsorship - The company received a notice from CITIC Securities regarding the change of sponsor representatives for its IPO project [1]. - Wang Qi, the previous sponsor representative, will no longer be responsible for the ongoing supervision due to a job change, and Shen Ziquan has been appointed as his replacement [1]. - The new sponsor representatives for the ongoing supervision of the IPO project are Zhang Lei and Shen Ziquan, with the supervision period lasting until the end of obligations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange [1]. Group 2: Acknowledgment of Contributions - The company's board expressed gratitude for Wang Qi's contributions during his tenure as a sponsor representative [2]. Group 3: Background of New Representative - Shen Ziquan, the new sponsor representative, is currently the Vice President of the Investment Banking Management Committee at CITIC Securities [3]. - He has been involved in various IPO projects and refinancing initiatives, maintaining a good record of compliance with relevant regulations [3].